Newest Omicron subvariants can evade boosters, antibody therapies
Wednesday, July 06, 2022 05:03 PM
The latest Omicron subvariants behind new COVID-19 surges in the United States and abroad have an enhanced ability to escape immunity conferred by three vaccine doses and all but one antibody therapy tested, finds a laboratory study published yesterday in Nature. Read more.